Recent studies showing PD‐L1 expression in the tumour microenvironment of MCCs, and PD‐1 expression by MCC‐specific tumour infiltrating and circulating T cells, supported investigating the utility of immune checkpoint inhibitors.11, 12. The gene discussed is CD274; the disease is neoplasm.